Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
398 |
|
| Actual shortage: | 9 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 40 (10%) | |
| Resolved: | 349 (88%) | |
Discontinuation Reports |
20 |
|
| To be discontinued: | 1 (5%) | |
| Discontinued: | 19 (95%) | |
| Reversed: | 0 (0%) | |
Late reports |
102 (24%) |
|
Overdue reports |
1 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| EDARBI | 40MG | TABLET | Resolved | 2024-12-18 | 2025-01-15 | 245958 |
| EDARBI | 40MG | TABLET | Resolved | 2025-06-04 | 2025-06-11 | 259463 |
| EDARBI | 80MG | TABLET | Resolved | 2019-09-10 | 2019-11-19 | 93523 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2018-08-24 | 2019-01-23 | 58987 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Avoided shortage | 2019-05-08 | 2019-05-23 | 83479 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2019-07-05 | 2019-08-14 | 88781 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2019-11-13 | 2020-01-23 | 98634 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2020-04-01 | 2020-04-24 | 110367 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2025-01-07 | 2025-04-09 | 247037 |
| EDARBYCLOR | 25MG 40MG | TABLET | Resolved | 2018-08-24 | 2018-11-09 | 58990 |
| EDARBYCLOR | 25MG 40MG | TABLET | Resolved | 2019-05-08 | 2019-11-19 | 83468 |
| EDARBYCLOR | 25MG 40MG | TABLET | Resolved | 2022-03-17 | 2022-04-07 | 156836 |
| EDECRIN | 25MG | TABLET | Resolved | 2018-10-19 | 2018-10-29 | 64977 |
| EFUDEX | 5% | CREAM | Resolved | 2020-04-09 | 2020-05-01 | 111790 |
| EFUDEX | 5% | CREAM | Resolved | 2023-10-19 | 2023-11-09 | 207370 |
| EFUDEX | 5% | CREAM | Resolved | 2023-12-15 | 2024-04-17 | 213446 |
| EFUDEX | 5% | CREAM | Resolved | 2024-05-01 | 2024-05-22 | 226785 |
| EFUDEX | 5% | CREAM | Resolved | 2024-10-10 | 2025-06-27 | 239776 |
| EFUDEX | 5% | CREAM | Resolved | 2025-07-09 | 2025-07-19 | 262320 |
| EFUDEX | 5% | CREAM | Avoided shortage | 2025-07-24 | 2025-10-16 | 263459 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| CARBOLITH | 300MG | CAPSULE | Discontinued | 2025-01-09 | 2025-01-09 | 247345 |
| CARBOLITH | 300MG | CAPSULE | Discontinued | 2025-01-09 | 2025-01-09 | 247352 |
| CARBOLITH | 150MG | CAPSULE | Discontinued | 2025-01-10 | 2025-01-23 | 247417 |
| CARBOLITH | 600MG | CAPSULE | Discontinued | 2025-01-10 | 2025-01-10 | 247420 |
| DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2025-04-15 | 212799 |
| MANERIX | 150MG | TABLET | Discontinued | 2025-01-07 | 2025-01-08 | 246998 |
| MANERIX | 300MG | TABLET | Discontinued | 2025-01-07 | 2025-01-08 | 247005 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
| VIRAZOLE | 6G | POWDER FOR SOLUTION AEROSOL | To be discontinued | 2025-11-18 | 2025-11-18 | 272123 |
| VITAMIN A ACID | 0.01% | GEL | Discontinued | 2024-01-30 | 2024-05-23 | 217835 |
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
Showing 1 to 20 of 20